Paradigm Burgenland: Risk of Borrelia burgdorferi sensu lato infection indicated by variable seroprevalence rates in hunters

Wiener Klinische Wochenschrift

Volumn 118, Issue 21-22, 2006, Pages 677-681

  Cetin, Emel ^a   Sotoudeh, Mahtab ^a   Auer, Herbert ^a   Stanek, Gerold ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Lyme borreliosis; Seroprevalence; Tick exposure

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ARTICLE; AUSTRIA; BLOOD SAMPLING; BORRELIA BURGDORFERI; BORRELIA INFECTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INCIDENCE; LYME DISEASE; MALE; OCCUPATIONAL EXPOSURE; RISK FACTOR; SEROPREVALENCE; TICK BITE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; AUSTRIA; BORRELIA BURGDORFERI GROUP; DATA INTERPRETATION, STATISTICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOBLOTTING; LOGISTIC MODELS; LYME DISEASE; MALE; MIDDLE AGED; OCCUPATIONS; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEROEPIDEMIOLOGIC STUDIES; TIME FACTORS;

EID: 33845606179     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-006-0694-y     Document Type: Article

References (15)

1. O'Connell S, Granström M, Gray JS, Stanek G (1998) Epidemiology of European Lyme Borreliosis. Zentralbl Bakteriol 287: 229-240
2. Christova I, Komitova R (2004) Clinical and epidemiological features of Lyme borreliosis in Bulgaria. Wien Klin Wochenschr 116: 42-46
3. Stanek G, Strle F (2003) Lyme borreliosis. Lancet 362: 1639-1647
4. Nadelmann RB, Wormser GP (1998) Lyme borreliosis. Lancet 352: 557-565
5. Strle F (1999) Principles of the diagnosis and antibiotic treatment of Lyme borreliosis. Wien Klin Wochenschr 111: 911-915
6. Anonymous (1995) Recommendations for test performance and interpretation from the second national conference on serological diagnosis of Lyme disease. Morb Mortal Wkly Rep 44: 590-591
7. Wilske B (2002) Microbiological diagnosis in Lyme borreliosis. Int J Med Microbiol 291 [Suppl 33]: 114-119
8. st edn. Urban and Fischer, Munich
9. Stanek G, Breier F, Menzinger G, Schaar B, Hafner M, Partsch H (1999) Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species. Wien Klin Wochenschr 111 (22-23): 951-956
10. Report of WHO workshop on Lyme Borreliosis diagnosis and surveillance (1996) Warsaw, Poland, 20-22 June, 1995, WHO/CDS/VPH/95. 141-1220
11. Berglund J, Eitrem R, Ornstein K, et al (1995) An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 333: 1319-1327
12. Strle F (1999) Lyme borreliosis in Slovenia. Zentralbl Bakteriol 289: 643-652
13. Campbell GL, Fritz CL, Fish D, Nowakowski J, Nadelman RB, Wormser GP (1998) Estimation of the incidence of Lyme disease. Am J Epidemiol 148: 1018-1026
14. Guy EC, Bateman DE, Martyn CN, Heckels JE, Lawton NF (1989) Lyme disease: prevalence and clinical importance of Borrelia burgdorferi specific IgG in forestry workers. Lancet 1(8636): 484-486
15. Hunfeld KP, Ernst M, Zachary P, Jaulhac B, Sonneborn HH, Brade V (2002) Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease. Wien Klin Wochenschr 114 (13-14): 580-585